Time-to-recovery from severe pneumonia and its predictors among children 2–59 months of age admitted to the pediatric ward of Jimma University Medical Center, Southwest Ethiopia, 2023: A retrospective cohort study
Open Access
- 15 April 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0316839
Abstract
Background: Pneumonia is an inflammation of lung parenchyma. The World Health Organization estimated 156 million cases of pneumonia occur annually. Out of them, 20 million cases severe enough to require hospitalization, and each year 1.2 million deaths occur among under-five children. Despite studies and initiatives aimed at reducing pneumonia related deaths in children, Ethiopia is ranked sixth among top fifteen countries in terms of pneumonia related morbidity and mortality. Objectives: This study aimed to assess the time to recovery from severe pneumonia and its predictors among children aged 2–59 months admitted to the pediatric ward of Jimma University Medical Center; Southwest, Ethiopia, 2023. Methods: A facility-based retrospective cohort study was carried out among 426 children aged between 2 and 59 months. Five years of medical records, from 2018–2022, were reviewed. A simple random sampling technique was used. Data entry was done in Epidata version 4.6 and exported to and analyzed by STATA version 15. Variables with p-value < 0.25 at Bivariable Cox regression analysis were selected for the multivariable Cox proportional model. A multivariable Cox regression model with 95% confidence interval and Adjusted Hazard Ratio was used to identify a significant predictor of time to recovery at a p-value < 0.05. Result: The median recovery time was 4 days (IQR: 3, 7). Incidence rate of recovery was 15.78 per 100-person day (95% CI 14.2–17.5). The presence of co-morbidity (AHR; 0.7, 95% CI (0.54–0.91)), being treated with Ceftazidime and Vancomycin (AHR; 0.29, 95% CI (0.14–0.60)), antibiotic change (AHR; 0.74, 95% CI (0.58–0.95)) and late presentation to the Hospital (AHR; 0.58, 95% CI (0.43–0.78)) were statistically significant predictors that prolong recovery time. Conclusion: The median recovery time was longer than other similar studies. Therefore, due attention should be given to the identified predictors of the recovery time.Keywords
This publication has 28 references indexed in Scilit:
- Time to recovery from severe acute malnutrition and its predictors among under five children admitted to therapeutic feeding units of general and referral hospitals in Tigray, Ethiopia, 2020: a prospective cohort studyBMC Pediatrics, 2023
- Risk factors associated with under-five stunting, wasting, and underweight in four provinces of the Democratic Republic of Congo: analysis of the ASSP project baseline dataBMC Public Health, 2022
- Underweight and its associated factors among pediatrics attending HIV Care in South Gondar Zone public health facilities, Northwest Ethiopia, 2021BMC Pediatrics, 2022
- Severe pneumonia: Treatment outcome and its determinant factors among under-five patients, Jimma, EthiopiaSage Open Medicine, 2022
- Exclusive breastfeeding practice and associated factors among first-time mothers in Bahir Dar city, North West Ethiopia: A community based cross sectional studyHeliyon, 2020
- Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysisThe Lancet Global Health, 2019
- Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug MonitoringJournal of Infection and Chemotherapy, 2013
- British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011Thorax, 2011
- Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is InadequateThe Pediatric Infectious Disease Journal, 2009
- Where and why are 10 million children dying every year?The Lancet, 2003